Group B streptococcus and early-onset sepsis in the era of maternal prophylaxis.
暂无分享,去创建一个
[1] A. Weyrich,et al. Comment on Chapter 5 , 1999 .
[2] T. Bodmer,et al. Group B Streptococcus colonization in pregnancy: prevalence and prevention strategies of neonatal sepsis , 2009, Journal of perinatal medicine.
[3] P. Hatton,et al. In vitro activity of an aqueous allicin extract and a novel allicin topical gel formulation against Lancefield group B streptococci. , 2008, The Journal of antimicrobial chemotherapy.
[4] S. Schrag,et al. Trends in perinatal group B streptococcal disease - United States, 2000-2006. , 2009, MMWR. Morbidity and mortality weekly report.
[5] I. Margarit,et al. Preventing bacterial infections with pilus-based vaccines: the group B streptococcus paradigm. , 2009, The Journal of infectious diseases.
[6] M. Edwards. Group B streptococcal conjugate vaccine: A timely concept for which the time has come , 2008, Human vaccines.
[7] P. Trieu-Cuot,et al. Invasive Group B Streptococcal Infections in Infants, France , 2008, Emerging infectious diseases.
[8] W. Schaffner,et al. Epidemiology of invasive group B streptococcal disease in the United States, 1999-2005. , 2008, JAMA.
[9] J. Sever,et al. Group B Streptococcus and pregnancy: a review. , 2008, American journal of obstetrics and gynecology.
[10] R. Baltimore,et al. Changing Patterns in Neonatal Escherichia coli Sepsis and Ampicillin Resistance in the Era of Intrapartum Antibiotic Prophylaxis , 2008, Pediatrics.
[11] V. Ganesh,et al. Duration of Antimicrobial Prophylaxis for Group B Streptococcus in Patients With Preterm Premature Rupture of Membranes Who Are Not in Labor , 2008 .
[12] Tiffany S. Glasgow,et al. Clinical and economic outcomes for term infants associated with increasing administration of antibiotics to their mothers. , 2007, Paediatric and perinatal epidemiology.
[13] T. Noakes,et al. Semmelweis and the aetiology of puerperal sepsis 160 years on: an historical review , 2007, Epidemiology and Infection.
[14] N. Ragni,et al. The efficacy of 2002 CDC guidelines in preventing perinatal group B Streptococcal vertical transmission: a prospective study , 2007, Archives of Gynecology and Obstetrics.
[15] R. Rappuoli,et al. Group B Streptococcus: global incidence and vaccine development , 2006, Nature Reviews Microbiology.
[16] Claudio Donati,et al. Microbial genomes and vaccine design: refinements to the classical reverse vaccinology approach. , 2006, Current opinion in microbiology.
[17] A. Schuchat,et al. Risk Factors for Invasive, Early-Onset Escherichia coli Infections in the Era of Widespread Intrapartum Antibiotic Use , 2006, Pediatrics.
[18] G. Natarajan,et al. Real-Time Polymerase Chain Reaction for the Rapid Detection of Group B Streptococcal Colonization in Neonates , 2006, Pediatrics.
[19] H. Leu,et al. Group B streptococcal bacteremia in non-pregnant adults. , 2006, Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi.
[20] C. Baker,et al. Prospects for prevention of childhood infections by maternal immunization , 2006, Current opinion in infectious diseases.
[21] H. Jörnvall,et al. Vernix caseosa as a multi-component defence system based on polypeptides, lipids and their interactions , 2005, Cellular and Molecular Life Sciences CMLS.
[22] C. Baker,et al. Group B streptococcal infections in elderly adults. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] B. Stoll,et al. Very Low Birth Weight Preterm Infants With Early Onset Neonatal Sepsis: The Predominance of Gram-Negative Infections Continues in the National Institute of Child Health and Human Development Neonatal Research Network, 2002–2003 , 2005, The Pediatric infectious disease journal.
[24] M. Weinstein,et al. The projected health benefits of maternal group B streptococcal vaccination in the era of chemoprophylaxis. , 2005, Vaccine.
[25] E. Eichenwald,et al. Early-Onset Group B Streptococcal Disease in the Era of Maternal Screening , 2005, Pediatrics.
[26] E. Lieberman,et al. No increase in rates of early-onset neonatal sepsis by antibiotic-resistant group B Streptococcus in the era of intrapartum antibiotic prophylaxis. , 2005, American journal of obstetrics and gynecology.
[27] C. Baker,et al. Group B streptococcal colonization and serotype-specific immunity in healthy elderly persons. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[28] J. M. Koenig,et al. Neonatal Neutrophils with Prolonged Survival Exhibit Enhanced Inflammatory and Cytotoxic Responsiveness , 2005, Pediatric Research.
[29] Vincent A. Fischetti,et al. Removal of Group B Streptococci Colonizing the Vagina and Oropharynx of Mice with a Bacteriophage Lytic Enzyme , 2005, Antimicrobial Agents and Chemotherapy.
[30] D. Laskin,et al. Mechanisms Underlying Reduced Apoptosis in Neonatal Neutrophils , 2005, Pediatric Research.
[31] M. Battin,et al. Escherichia coli: a growing problem in early onset neonatal sepsis , 2004, The Australian & New Zealand journal of obstetrics & gynaecology.
[32] M. Bergeron,et al. Laboratory detection of group B Streptococcus for prevention of perinatal disease , 2004, European Journal of Clinical Microbiology and Infectious Diseases.
[33] A. Schuchat,et al. Trends in Sepsis-Related Neonatal Mortality in the United States, 1985–1998 , 2004, The Pediatric infectious disease journal.
[34] V. Nizet,et al. Extracellular virulence factors of group B Streptococci. , 2004, Frontiers in bioscience : a journal and virtual library.
[35] A. Alarcon,et al. Neonatal early onset Escherichia coli sepsis: trends in incidence and antimicrobial resistance in the era of intrapartum antimicrobial prophylaxis , 2004, The Pediatric infectious disease journal.
[36] D. Kasper,et al. Immune response of healthy women to 2 different group B streptococcal type V capsular polysaccharide-protein conjugate vaccines. , 2004, The Journal of infectious diseases.
[37] M. Yoder,et al. Neonatal neutrophils: the good, the bad, and the ugly. , 2004, Clinics in perinatology.
[38] W. Keitel,et al. Healthy Elderly People Lack Neutrophil‐Mediated Functional Activity to Type V Group B Streptococcus , 2004, Journal of the American Geriatrics Society.
[39] R. Rappuoli,et al. New Generation Vaccines, 3rd Edition , 2004 .
[40] L. Paoletti,et al. Oxygen Regulates Invasiveness and Virulence of Group B Streptococcus , 2003, Infection and Immunity.
[41] C. Baker,et al. Immunization of pregnant women with group B streptococcal type III capsular polysaccharide-tetanus toxoid conjugate vaccine. , 2003, Vaccine.
[42] M. Pearlman. Prevention of early-onset group B streptococcal disease in newborns. , 2003, Obstetrics and gynecology.
[43] Stephanie Schrag,et al. Prevention of Perinatal Group B Streptococcal Disease Revised Guidelines from CDC , 2002 .
[44] K. O'Brien,et al. Trends in incidence and antimicrobial resistance of early-onset sepsis: population-based surveillance in San Francisco and Atlanta. , 2002, Pediatrics.
[45] C. Baker. CDC revises group B strep prevention guidelines , 2002 .
[46] G. Sanders,et al. Perinatal screening for group B streptococci: cost-benefit analysis of rapid polymerase chain reaction. , 2002, Pediatrics.
[47] W. Poole,et al. Changes in pathogens causing early-onset sepsis in very-low-birth-weight infants. , 2002, The New England journal of medicine.
[48] A. Baxter. Louis Pasteur's beer of revenge , 2001, Nature Reviews Immunology.
[49] S. Kenyon,et al. Broad-spectrum antibiotics for preterm, prelabour rupture of fetal membranes: the ORACLE I randomised trial , 2001, The Lancet.
[50] D. Kasper,et al. Use of capsular polysaccharide-tetanus toxoid conjugate vaccine for type II group B Streptococcus in healthy women. , 2000, The Journal of infectious diseases.
[51] R. Platt,et al. Invasive disease due to group B Streptococcus in pregnant women and neonates from diverse population groups. , 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[52] A. Schuchat,et al. Group B streptococcal disease in the era of intrapartum antibiotic prophylaxis. , 2000, The New England journal of medicine.
[53] R. Rappuoli. Reverse vaccinology : Genomics , 2000 .
[54] J. Hadler,et al. From the Centers for Disease Control and Prevention: early-onset group B streptococcal disease--United States, 1998-1999. , 2000, JAMA.
[55] P. Ferrieri,et al. Changing Epidemiology of Group B Streptococcal Colonization , 1999, Pediatrics.
[56] R. Platt,et al. Resource utilization associated with initial hospital stays complicated by early onset group B streptococcal disease. , 1999, The Pediatric infectious disease journal.
[57] T. Raju. Ignác Semmelweis and the Etiology of Fetal and Neonatal Sepsis , 1999, Journal of Perinatology.
[58] D. Kasper,et al. Serotypes VI and VIII predominate among group B streptococci isolated from pregnant Japanese women. , 1999, The Journal of infectious diseases.
[59] G. Escobar,et al. Preventing Neonatal Group B Streptococcal Disease: Cost-Effectiveness in a Health Maintenance Organization and the Impact of Delayed Hospital Discharge for Newborns Who Received Intrapartum Antibiotics , 1999, Pediatrics.
[60] A. Schuchat. Group B streptococcus , 1999, The Lancet.
[61] D. Kasper,et al. Safety and immunogenicity of capsular polysaccharide-tetanus toxoid conjugate vaccines for group B streptococcal types Ia and Ib. , 1999, The Journal of infectious diseases.
[62] J. M. Koenig,et al. Spontaneous and Fas‐mediated apoptosis are diminished in umbilical cord blood neutrophils compared with adult neutrophils , 1998, Journal of leukocyte biology.
[63] A. Schuchat. Epidemiology of Group B Streptococcal Disease in the United States: Shifting Paradigms , 1998, Clinical Microbiology Reviews.
[64] J. Schollin,et al. Impaired phagocytosis and opsonisation towards group B streptococci in preterm neonates , 1998, Archives of disease in childhood. Fetal and neonatal edition.
[65] L. Wright,et al. Revised guidelines for prevention of early-onset group B streptococcal (GBS) infection. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn. , 1997, Pediatrics.
[66] C. Baker,et al. Group B streptococcal infections. , 1997, Clinics in perinatology.
[67] J. Tyson,et al. Early-onset sepsis in very low birth weight neonates: a report from the National Institute of Child Health and Human Development Neonatal Research Network. , 1996, The Journal of pediatrics.
[68] A. Schuchat,et al. Prevention of perinatal group B streptococcal disease : a public health perspective , 1996 .
[69] A. Spitzer,et al. Intensive Care Of The Fetus And Neonate , 1996 .
[70] R. Gibson,et al. Group B streptococci (GBS) injure lung endothelium in vitro: GBS invasion and GBS-induced eicosanoid production is greater with microvascular than with pulmonary artery cells , 1995, Infection and immunity.
[71] K. Tullus,et al. Correlation between susceptibility of infants to infections and interaction with neutrophils of Escherichia coli strains causing neonatal and infantile septicemia. , 1995, The Journal of infectious diseases.
[72] C. Rubens,et al. Adherence of group B streptococci to cultured epithelial cells: roles of environmental factors and bacterial surface components , 1994, Infection and immunity.
[73] F. Noya,et al. Neutrophil Fc receptor participation in phagocytosis of type III group B streptococci , 1993, Infection and immunity.
[74] C. Baker,et al. Fibronectin levels in premature infants with late-onset sepsis. , 1993, Journal of perinatology : official journal of the California Perinatal Association.
[75] C. Broome,et al. American Academy of Pediatrics Committee on Infectious Diseases and Committee on Fetus and Newborn: Guidelines for prevention of group B streptococcal (GBS) infection by chemoprophylaxis. , 1992, Pediatrics.
[76] J. Campbell,et al. Deposition and degradation of C3 on type III group B streptococci , 1991, Infection and immunity.
[77] S. Garland,et al. Group B Streptococcus (GBS) and Neonatal Infections: The Case for Intrapartum Chemoprophylaxis , 1991, The Australian & New Zealand journal of obstetrics & gynaecology.
[78] H. Hill,et al. Effect on neutrophil kinetics and serum opsonic capacity of intravenous administration of immune globulin to neonates with clinical signs of early-onset sepsis. , 1991, The Journal of pediatrics.
[79] R. Matorras,et al. Maternal colonization by group B streptococci and puerperal infection; analysis of intrapartum chemoprophylaxis. , 1991, European journal of obstetrics, gynecology, and reproductive biology.
[80] Gary J. Nabel,et al. New Generation Vaccines , 1990 .
[81] V. Nizet,et al. Chapter 13 – Group B Streptococcal Infections , 1990 .
[82] D. Anderson,et al. Role of complement receptors in opsonophagocytosis of group B streptococci by adult and neonatal neutrophils. , 1990, The Journal of infectious diseases.
[83] M. Berger. Complement deficiency and neutrophil dysfunction as risk factors for bacterial infection in newborns and the role of granulocyte transfusion in therapy. , 1990, Reviews of infectious diseases.
[84] Quie Pg. Antimicrobial defenses in the neonate. , 1990 .
[85] Anderson Dc. Neonatal neutrophil dysfunction. , 1992 .
[86] M. Hallman,et al. Prevention of Neonatal Group B Streptococcal Disease: Intrapartum Detection and Chemoprophylaxis of Heavily Colonized Parturients , 1989, Obstetrics and gynecology.
[87] C. Baker,et al. Fibronectin and age-limited susceptibility to type III, group B Streptococcus. , 1988, The Journal of infectious diseases.
[88] C. Baker,et al. Type III group B Streptococcus: functional interaction with IgG subclass antibodies. , 1987, The Journal of infectious diseases.
[89] K. Boyer,et al. Prevention of early‐onset neonatal group B streptococcal disease with selective intrapartum chemoprophylaxis , 1986, The New England journal of medicine.
[90] R. Feigin,et al. Textbook of Pediatric Infectious Diseases , 1986 .
[91] I. Loudon. Deaths in childbed from the eighteenth century to 1935. , 1986, Medical History.
[92] C. Wilson,et al. Immunologic basis for increased susceptibility of the neonate to infection. , 1986, The Journal of pediatrics.
[93] A. Forsgren,et al. Group B streptococci at delivery: high count in urine increases risk for neonatal colonization. , 1986, Scandinavian journal of infectious diseases.
[94] D. Kasper,et al. Group B streptococcal vaccines. , 1985, Reviews of infectious diseases.
[95] H. Hill,et al. Fatal early onset Group B streptococcal sepsis with normal leukocyte counts , 1985, Pediatric infectious disease.
[96] A. Forsgren,et al. Asymptomatic bacteriuria during pregnancy with special reference to group B streptococci. , 1985, Scandinavian journal of infectious diseases.
[97] D. Kasper,et al. The role of complement in opsonization of GBS. , 1985, Antibiotics and chemotherapy.
[98] R. Polin,et al. Diminished Bactericidal Capacity for Group B Streptococcus in Neutrophils from “Stressed” and Healthy Neonates , 1984, Pediatric Research.
[99] K. Boyer,et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. II. Predictive value of prenatal cultures. , 1983, The Journal of infectious diseases.
[100] K. Boyer,et al. Selective intrapartum chemoprophylaxis of neonatal group B streptococcal early-onset disease. I. Epidemiologic rationale. , 1983, The Journal of infectious diseases.
[101] J. Klein,et al. Infectious Diseases of the Fetus and Newborn Infant , 1983 .
[102] C. Baker,et al. Impaired Chemotaxigenesis by Type III Group B Streptococci in Neonatal Sera: Relationship to Diminished Concentration of Specific Anticapsular Antibody and Abnormalities of Serum Complement , 1983, Pediatric Research.
[103] D. Kasper,et al. Capsular sialic acid prevents activation of the alternative complement pathway by type III, group B streptococci. , 1982, Journal of immunology.
[104] D. Kasper,et al. Role of antibody to native type III polysaccharide of group B Streptococcus in infant infection. , 1981, Pediatrics.
[105] H. Dillon,et al. A prospective study of group B streptococcal bacteriuria in pregnancy. , 1981, American journal of obstetrics and gynecology.
[106] H. Hill,et al. Defective oxidative metabolic responses of neutrophils from stressed neonates. , 1981, The Journal of pediatrics.
[107] C. Baker,et al. Group B streptococcal infections , 1999 .
[108] R. Christensen,et al. Exhaustion of mature marrow neutrophils in neonates with sepsis. , 1980, The Journal of pediatrics.
[109] H. Hill,et al. Functional analysis of neutrophil granulocytes from healthy, infected, and stressed neonates. , 1979, The Journal of pediatrics.
[110] E. Mason,et al. Ampicillin prevents intrapartum transmission of group B streptococcus. , 1979, JAMA.
[111] B. Curfman,et al. Experimental group B streptococcal infection in the rhesus monkey. I. Disease production in the neonate. , 1978, American journal of obstetrics and gynecology.
[112] F. Barrett,et al. Group B streptococcal infections in infants. The importance of the various serotypes. , 1974, JAMA.
[113] F. Barrett,et al. Transmission of group B streptococci among parturient women and their neonates. , 1973, The Journal of pediatrics.
[114] R. Facklam,et al. Distribution by Serological Type of Group B Streptococci Isolated from a Variety of Clinical Material over a Five-Year Period (with Special Reference to Neonatal Sepsis and Meningitis) , 1973, Infection and immunity.
[115] R. Feigin,et al. Group B beta hemolytic streptococcal meningitis in infants. , 1973, The Journal of pediatrics.
[116] M. Finland,et al. NEONATAL SEPSIS AND OTHER INFECTIONS DUE TO GROUP B BETA-HEMOLYTIC STREPTOCOCCI. , 1964, The New England journal of medicine.
[117] George W. Dameron,et al. Beta hemolytic streptococcus group B associated with problems of the perinatal period. , 1961, American journal of obstetrics and gynecology.
[118] R. Fry. FATAL INFECTIONS BY HÆMOLYTIC STREPTOCOCCUS GROUP B , 1938 .
[119] R. Lancefield,et al. THE SEROLOGICAL DIFFERENTIATION OF PATHOGENIC AND NON-PATHOGENIC STRAINS OF HEMOLYTIC STREPTOCOCCI FROM PARTURIENT WOMEN , 1935, The Journal of experimental medicine.
[120] Pasteur. ON THE GERM THEORY. , 1881, Science.